Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluating the efficacy and safety of generics caspofungin in
the treatment of the patients with neutropenic and fever.Another purpose of this study is
comparing the pharmacokinetic characteristics of generics caspofungin and original
medicine(Cancidas®) for providing a basis for clinical rational administration.